they last reported sales were up 59% and profits were FAT because most of their revenues are from royalties so cost of sales is near zero.
This looks like a reasonable spot to buy in front of earnings.
www.earningswhispers.com
The Bull Market is strong, the end of 2020 saw many growth names pull in or consolidate which gives a better reward to risk entry. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 30 total stocks on this list. I add an additional 3 stocks that...
#LGND. The share has been in consolidation for a month now in the range of 108-118. EMA50 is preparing to pass EMA100 from bottom to top on the daily chart, which will be a strong enough signal to buy. If out of the range, the growth can be explosive, as Short Float is 58.36% Possible TP levels are shown on the chart.
LGND seems breaking down from a (possible) H&S formation. It broke its neckline on strong volume. We are keeping it on our watch list as a potential short.
Please check back for Trade updates. (Note: Trade update is little delayed here.)
Right at a support from horizontal and rising trendline. RSI and MACD are way oversold and is at place where it bounced last time at these levels.200dma support right underneath. Some bounce here should be certainly in. If not then it would provide a good short opportunity with a stop just above 111.
Fundamentals :
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than average risk.
Ligand's P/E of 8 is cheap as I...
